Primary tabs

Other Access

The information on this page (the dataset metadata) is also available in these formats.

JSON RDF

via the DKAN API

Prospective double-blind placebo-controlled randomized parallel-group multi-center study with an open-label extension period to investigate the efficacy and safety of two different doses of NT 201 in Botulinum toxin treatment-nave subjects with...

This phase 3 study will serve to collect efficacy and safety data of two different doses of NT 201 in subjects suffering from BEB who are BTX treatment-nave In this study BTX treatment-nave subjects are defined as those who have not received BTX treatment within the last 12 months for the treatment of BEB This definition aims to avoid bias by comparison of treatment effects in the subjects assessments Furthermore this study will substantiate the existing efficacy and safety database for the indication BEB

FieldValue
Modified
2020-03-29
Release Date
2018-06-21
Identifier
f70f2cd9-af04-46a4-95de-ef0088a73a6a
License
Public Access Level
Public